After the Covishield vaccine maker AstraZeneca has accepted Thrombosis with Thrombocytopenia Syndrome (TTS) as a side effect in UK Courts, the Doctors’ body has urged center to compensate all the victims of Covid...
For the first time post Covid period, the Covishield vaccine maker AstraZeneca has admitted that its vaccine can cause rare side effects. In India, Serum Institute of India (SII) has manufactured and supplied the Covishield...
The centre on Wednesday reduced the gap of booster doses from existing 9 months or 39 weeks to 6 months or 26 weeks.The ministry said that as per the recommendation, it has been decided all beneficiaries from 18- 59 years...
The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap of Covid vaccine Covishield to 8 to 16 weeks after 1st dose of vaccine in view of ongoing Omicron pandemic, said a source on...
United Nations Secretary General Antonio Guterres on Thursday admired India’s vaccine production capacity and said it is the “best asset” that the world has today. United Nations Secretary General Antonio...
After such huge number of deaths, the country has launched a detailed investigation into the reported fatalities. The report has confirmed that total 23 elderly patients have died following immunization with the...
The letter said that Covaxin manufactured by Bharat Biotech is being preferred in RML Hospital over Covishield developed by Serum Institute. The Resident Doctors’ Association (RDA) of the Ram Manohar Lohia Hospital on...
Prime Minister Narendra Modi will chair a meeting on Monday with states’ chief ministers to discuss the vaccine rollout. Prime Minister Narendra Modi will chair a meeting on Monday with states’ chief ministers to discuss...
Health Ministry informed that India’s biggest adult vaccination drive will be taken by the central government. The Union Health Ministry said on Tuesday that companies developing indigenous vaccines against COVID19 were...
